does glp-1 help with inflammation and Gut Health: Addressing Metabolic Dysfunction for Physicians GLP-1 for Weight Loss and

GLP-1 receptor agonists were developed primarily to treat type 2 diabetes and were later approved for chronic weight management

and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal

While both platforms support prescription access, they differ in how they approach ongoing support, provider interaction, and care personalization

They review health questionnaire submissions, determine whether GLP-1 treatment is appropriate, recommend specific medications and starting doses, and issue prescriptions when clinically warranted

This system historically has required clinics or hospitals to subscribe to the company to use its devices